318 related articles for article (PubMed ID: 19233960)
1. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
Petrella RJ; Merikle E; Jones J
Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
[TBL] [Abstract][Full Text] [Related]
3. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for statin-associated rhabdomyolysis.
Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
[TBL] [Abstract][Full Text] [Related]
5. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
Ye X; Gross CR; Schommer J; Cline R; St Peter WL
Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
[TBL] [Abstract][Full Text] [Related]
6. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL
Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174
[TBL] [Abstract][Full Text] [Related]
7. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
8. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
McClure DL; Valuck RJ; Glanz M; Murphy JR; Hokanson JE
J Clin Epidemiol; 2007 Aug; 60(8):812-8. PubMed ID: 17606177
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk factors associated with lipid-lowering drug-induced myopathies.
Vladutiu GD; Simmons Z; Isackson PJ; Tarnopolsky M; Peltier WL; Barboi AC; Sripathi N; Wortmann RL; Phillips PS
Muscle Nerve; 2006 Aug; 34(2):153-62. PubMed ID: 16671104
[TBL] [Abstract][Full Text] [Related]
10. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
11. Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort).
Gardette V; Bongard V; Dallongeville J; Arveiler D; Bingham A; Ruidavets JB; Amouyel P; Haas B; Ducimetière P; Ferrières J
Am J Cardiol; 2009 Feb; 103(3):381-6. PubMed ID: 19166693
[TBL] [Abstract][Full Text] [Related]
12. Analgesic drug use associated with statin prescription--a cross-sectional study in primary care settings.
Mosshammer D; Schwarz J; Meznaric S; Muche R; Lorenz G; Mörike K
Curr Drug Saf; 2012 Feb; 7(1):16-20. PubMed ID: 22663951
[TBL] [Abstract][Full Text] [Related]
13. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA
Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281
[TBL] [Abstract][Full Text] [Related]
14. Myotoxicity associated with lipid-lowering drugs.
Baer AN; Wortmann RL
Curr Opin Rheumatol; 2007 Jan; 19(1):67-73. PubMed ID: 17143099
[TBL] [Abstract][Full Text] [Related]
15. Differential association between statin exposure and elevated levels of creatine kinase.
Chan J; Hui RL; Levin E
Ann Pharmacother; 2005 Oct; 39(10):1611-6. PubMed ID: 16160000
[TBL] [Abstract][Full Text] [Related]
16. Statin-induced muscular symptoms: a report of 3 cases.
Kumar AJ; Wong SK; Andrew G
Acta Orthop Belg; 2008 Aug; 74(4):569-72. PubMed ID: 18811049
[TBL] [Abstract][Full Text] [Related]
17. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.
Ashworth M; Lloyd D; Smith RS; Wagner A; Rowlands G
J Public Health (Oxf); 2007 Mar; 29(1):40-7. PubMed ID: 17071815
[TBL] [Abstract][Full Text] [Related]
18. Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?
Lacut K; Le Gal G; Abalain JH; Mottier D; Oger E
Thromb Res; 2008; 122(3):314-9. PubMed ID: 18048086
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in 45 patients with statin-associated myopathy.
Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
[TBL] [Abstract][Full Text] [Related]
20. Factors related to adherence to statin therapy.
McGinnis B; Olson KL; Magid D; Bayliss E; Korner EJ; Brand DW; Steiner JF
Ann Pharmacother; 2007 Nov; 41(11):1805-11. PubMed ID: 17925498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]